COMMUNIQUÉS West-GlobeNewswire

Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors
16/05/2018
MEDFORD, N.Y., May 16, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that John Potthoff, Ph.D., has been [...]
EY Announces that Sabrina Martucci Johnson, CEO of Daré Bioscience, Inc., is an Entrepreneur Of The Year® 2018 Award Finalist in San Diego
16/05/2018
SAN DIEGO, May 16, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company focused on women’s sexual and reproductive health, announced today that President [...]
Agritek Holdings Inc. Announces Timely Filing of Quarterly Report, Now Focused On Revenue, Acquisitions, and International Growth For Profitability in 2018
16/05/2018
LOS ANGELES, CA, May 16, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
Insmed Announces FDA Acceptance for Filing of New Drug Application for ALIS in NTM Lung Disease Caused by MAC
16/05/2018
PDUFA Action Date Set for September 28, 2018 BRIDGEWATER, N.J., May 16, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare [...]
PolarityTE Announces Rich Haerle as the New Vice President of Investor Relations and Corporate Strategy
16/05/2018
PolarityTE to open New York City satellite office for Investor Relations SALT LAKE CITY, May 16, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) today announced the appointment of Rich Haerle as Vice President [...]
Prostate cancer discovery enabled by Biolog technology
16/05/2018
HAYWARD, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- A discovery made using Phenotype MicroArray™ technology has led to a deeper understanding of the lethal role of the PTEN null mutation in prostate cancer while also [...]
ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections
16/05/2018
Fourth Patent Issued to the Company in the U.S. Provides Coverage for RI-002 Through 2035 RAMSEY, N.J. and BOCA RATON, Fla., May 16, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company [...]
K2M Announces US Launch of First-to-Market 3D-Printed Expandable Interbody MOJAVE™ PL 3D Expandable Featuring Lamellar 3D Titanium Technology™
16/05/2018
Next-generation 3D-printed expandable fusion device is the first and only to feature infinite adjustment within its expansion range to help restore sagittal balance in spine deformity patients LEESBURG, Va., May 16, [...]
ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update
16/05/2018
-Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109 in Endometriosis, results expected by the end of Q2:18, and Primary endpoint achieved in Phase [...]
Evolus to Provide Regulatory Update on Wednesday, May 16, 2018
16/05/2018
IRVINE, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS ) (“Evolus”), a lifestyle aesthetics company focused on delivering advanced aesthetic procedures and treatments to physicians and consumers, [...]
Aclaris Therapeutics Announces Poster Presentations at International Investigative Dermatology 2018 Meeting
16/05/2018
WAYNE, Pa., May 16, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS ), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.
16/05/2018
WATERTOWN, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT ), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
ESPERITE NV (ESP) WITH CRYOSAVE TAKES OVER FULL CONTROL OF BUSINESS IN SOUTH AFRICA AND INTEND TO DISTRIBUTE ADVANCED SERVICES TO THE GROWING AFRICAN POPULATION
16/05/2018
Amsterdam, the Netherlands - 16 May 2018 Esperite NV, The Regenerative and predictive medicine company has acquired control of its long-term South African joint venture CryoSave South Africa Ltd. Effective 1 April 2018 [...]
LIDDS: Delårsrapport januari-mars 2018
16/05/2018
FÖRSTA KVARTALET: JANUARI - MARS 2018 Nettoomsättningen uppgick till 0,0 (0,0) KSEK Kostnaderna uppgick till 2,0 (1,8) MSEK Resultatet före och efter skatt uppgick till -2,0 (-1,8) MSEK Resultat per aktie uppgick till - [...]
Terveystalo Plc: Terveystalo Group Interim Report January 1 - March 31, 2018
16/05/2018
Terveystalo Plc Interim report 16 May 2018 at at 9:00 a.m. EEST CONTINUOUS SALES AND EARNINGS GROWTH Highlights of the review period January-March 2018 Revenue increased by 23 per cent year-on-year to EUR 197.5 million [...]
Kiadis Pharma to Present at Upcoming Investor Conferences
16/05/2018
Kiadis Pharma to Present at Upcoming Investor Conferences Amsterdam, The Netherlands, May 16, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical stage [...]
Shire plc: Rule 2.9 Announcement
16/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 16 May 2018 Shire [...]
DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors
16/05/2018
Montrouge, France, May 16, 2018 DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage [...]
DBV Technologies annonce la nomination de Michel de Rosen à son Conseil d'administration
16/05/2018
Montrouge, France, le 16 mai (07h30 CEST) 2018 DBV Technologies annonce la nomination de Michel de Rosen à son Conseil d'administration DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]

Pages